Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Current Assets (2011 - 2026)

Palatin Technologies' (PTN) quarterly Current Assets came in at $12.8 million in Q1 2026, up 295.43% on a YoY basis from $3.2 million in Q1 2025, and down 26.81% quarter-over-quarter from $17.5 million in Q4 2025.

Analysis

Palatin Technologies (PTN) Current Assets (2011 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Current Assets for 15 consecutive years, with $12.8 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Current Assets rose 295.43% year-over-year to $12.8 million; the trailing twelve-month figure through Mar 2026 stood at $12.8 million (up 295.43% YoY), and the FY2025 full-year result was $2.9 million, down 70.12% from the prior year.
  • Current Assets eased to $12.8 million in Q1 2026 per PTN's latest filing, from $17.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $42.2 million in Q1 2022 and bottomed at $2.6 million in Q3 2024.
  • Historically, Current Assets has averaged $15.7 million across 5 years, with a median of $12.2 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Current Assets tumbled 73.36% in 2024, then surged 375.99% in 2025.
  • Over 5 years, Current Assets stood at $30.6 million in 2022, then plunged by 59.92% to $12.2 million in 2023, then plunged by 70.03% to $3.7 million in 2024, then soared by 375.99% to $17.5 million in 2025, then decreased by 26.81% to $12.8 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $12.8 million, $17.5 million, and $8.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 34.96 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 13.95 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 12.54 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 18.45 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 8.07 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.82 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 4.62 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 7.31 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 4.74 Bn
10 Palatin Technologies 46.98 Mn 46.98 Mn - 12.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 12.79 Mn
Dec 31, 2025 17.47 Mn
Sep 30, 2025 8.37 Mn
Jun 30, 2025 2.92 Mn
Mar 31, 2025 3.23 Mn
Dec 31, 2024 3.67 Mn
Sep 30, 2024 2.61 Mn
Jun 30, 2024 9.77 Mn
Mar 31, 2024 10.27 Mn
Dec 31, 2023 12.25 Mn
Sep 30, 2023 9.81 Mn
Jun 30, 2023 16.32 Mn
Mar 31, 2023 24.24 Mn
Dec 31, 2022 30.55 Mn
Sep 30, 2022 26.18 Mn
Jun 30, 2022 34.60 Mn
Mar 31, 2022 42.25 Mn
Dec 31, 2021 51.37 Mn
Sep 30, 2021 58.39 Mn
Jun 30, 2021 65.91 Mn